+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sustained Release Injectables Market - Global Forecast 2026-2032- Product Image
Sustained Release Injectables Market - Global Forecast 2026-2032- Product Image
New

Sustained Release Injectables Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 183 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5533434
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The sustained release injectables market is undergoing significant transformation, shaped by intersecting advances in formulation science, medical device engineering, and patient-centric drug delivery. Senior executives in pharmaceutical and medical device industries must navigate rapid technology evolution, changing regulations, and global supply chain shifts to advance strategic objectives efficiently in this sector.

Market Snapshot: Sustained Release Injectables

The sustained release injectables market realized growth from USD 2.45 billion in 2025 to USD 2.60 billion in 2026 and is projected to expand at a CAGR of 7.24%, reaching USD 4.01 billion by 2032. This upward trend reflects expanding adoption of long-acting therapeutics, increased demand for innovative formulation technologies, and the optimization of healthcare delivery workflows worldwide. Market momentum is influenced by investments in advanced drug delivery, patient adherence solutions, and regulatory clarity across mature and emerging economies.

Scope & Segmentation

  • Product Formats: Cartridges, implantable pumps, pre-filled syringes, and unfilled vials drive variability in dosing precision, sterility maintenance, and user handling, making format selection pivotal for clinical success.
  • Polymer Chemistries: Includes both biodegradable polymers such as PCL, PLA, PLGA (supporting controlled resorption and biointegration) and non-biodegradable materials like polyethylene and polysiloxanes, which extend formulation stability.
  • Administration Routes: Options encompass epidural, intramuscular, intravitreal, and subcutaneous delivery pathways. Each route presents unique safety profiles, operational challenges, and trial design complexities, impacting commercial strategies.
  • Therapeutic Niches: Applications span hormonal therapies, solid tumor and hematologic oncology, pain management, and vaccine delivery. Each indication demands bespoke evidence packages, regulatory navigation, and clinical workflow integration.
  • End-User Environments: User sites range from ambulatory surgical centers and clinics to hospitals and the growing home healthcare segment. Diverse settings require customization of device ergonomics, training solutions, and support infrastructure.
  • Regions: Coverage includes North America, Europe, Middle East & Africa, and Asia-Pacific, each shaping regional compliance, manufacturing logistics, and commercialization strategies to meet local market needs.

Key Takeaways: Strategic Insights

  • Sustained release injectables are shifting from specialized use to broader adoption in both chronic and acute care management, enhancing patient adherence and care outcomes.
  • Technological development in polymers and device engineering is improving release kinetics and enhancing biocompatibility, allowing entry into previously underserved patient cohorts and indications.
  • Mature regulatory frameworks are reducing approval uncertainties for combination products, which encourages capital allocation and regional market launches.
  • Effective product development strategies now require granular segmentation, from device format innovations in pre-filled syringes for hormone regulation to robust implantable solutions for oncology care.
  • Cross-functional collaboration across R&D, regulatory, health economics, supply, and commercial operations remains essential for timely and effective market entry.
  • Regional adaptation—such as aligning to specific reimbursement approaches in Europe or strategic manufacturing partnerships in Asia-Pacific—increases resilience and leadership capability across global markets.

Sustained Release Injectables Market: Tariff Impact

Recent U.S. tariff policies implemented in 2025 have influenced the sustained release injectables value chain, adding cost pressures to polymers, device parts, and active pharmaceutical ingredients. Companies are now adjusting sourcing strategies by diversifying supplier bases, certifying alternative materials, and increasing transparency in inventory management. Manufacturing decisions must increasingly balance market access proximity with tariff risk exposure. This holistic approach strengthens supply chain resilience and mitigates against unanticipated mid-production cost volatility, supporting stable operations in a dynamic geopolitical environment.

Methodology & Data Sources

This market analysis draws on interviews with formulation scientists, regulatory experts, and clinicians, augmented by thorough peer-reviewed literature review, regulatory guidelines, and clinical trial data. Strategic recommendations are validated through scenario modeling and triangulation of multiple data sources to ensure reliability and applicability.

Sustained Release Injectables Market: Why This Report Matters

  • Helps senior decision-makers align R&D, manufacturing, and real-world evidence programs with changing market and policy conditions across all target regions.
  • Provides practical insight into optimizing supply networks, regulatory submission pathways, and commercialization models specific to each product segment and geography.
  • Equips executives with a comprehensive view of technology trends, competitor positioning, and regulatory priorities to guide investment, partnership, and growth decisions.

Conclusion

Effective integration across scientific, regulatory, and commercial teams is essential for advancing long-acting injectable strategies. Operational discipline and regional adaptation support lasting market and patient impact. Leaders poised to synchronize innovation, compliance, and supply agility will secure long-term value in the sustained release injectables market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Sustained Release Injectables Market, by Product Type
8.1. Cartridges
8.2. Implantable Pumps
8.3. Pre-Filled Syringes
8.4. Unfilled Vials
9. Sustained Release Injectables Market, by Polymer Type
9.1. Biodegradable Polymers
9.1.1. PCL
9.1.2. PLA
9.1.3. PLGA
9.2. Non-Biodegradable Polymers
9.2.1. Polyethylene
9.2.2. Polysiloxanes
10. Sustained Release Injectables Market, by Route Of Administration
10.1. Epidural
10.2. Intramuscular
10.3. Intravitreal
10.4. Subcutaneous
11. Sustained Release Injectables Market, by Application
11.1. Hormonal Therapies
11.2. Oncology
11.2.1. Hematological Malignancies
11.2.2. Solid Tumors
11.2.2.1. Breast Cancer
11.2.2.2. Lung Cancer
11.3. Pain Management
11.4. Vaccines
12. Sustained Release Injectables Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Clinics
12.3. Home Healthcare
12.4. Hospitals
13. Sustained Release Injectables Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Sustained Release Injectables Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Sustained Release Injectables Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Sustained Release Injectables Market
17. China Sustained Release Injectables Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Alkermes plc
18.6. B. Braun Melsungen AG
18.7. Baxter International Inc.
18.8. DSM-Firmenich Group
18.9. DURECT Corporation
18.10. Eli Lilly and Company
18.11. GlaxoSmithKline plc
18.12. Halozyme Therapeutics, Inc.
18.13. Hoffmann-La Roche Ltd
18.14. Indivior PLC
18.15. Johnson & Johnson
18.16. MedinCell SA
18.17. Novartis AG
18.18. Oakwood Laboratories, LLC
18.19. Otsuka Pharmaceutical Co., Ltd.
18.20. Pfizer Inc.
18.21. Pharmathen S.A.
18.22. Sanofi S.A.
18.23. Teva Pharmaceutical Industries Ltd.
18.24. ViiV Healthcare Limited
List of Figures
FIGURE 1. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY IMPLANTABLE PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY IMPLANTABLE PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY IMPLANTABLE PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY UNFILLED VIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY UNFILLED VIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY UNFILLED VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PCL, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PCL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PCL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PLA, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PLA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PLA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PLGA, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PLGA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PLGA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYSILOXANES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYSILOXANES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYSILOXANES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY EPIDURAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY EPIDURAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY INTRAVITREAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY INTRAVITREAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY INTRAVITREAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HORMONAL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HORMONAL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. EUROPE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. EUROPE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. EUROPE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 137. EUROPE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 138. EUROPE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 141. EUROPE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 142. EUROPE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 156. AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 157. AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 158. AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 159. AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 161. AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 162. AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. ASEAN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. ASEAN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 176. ASEAN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 177. ASEAN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 178. ASEAN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 179. ASEAN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 180. ASEAN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. ASEAN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 182. ASEAN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 183. ASEAN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. GCC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GCC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. GCC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 187. GCC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 188. GCC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 189. GCC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 190. GCC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. GCC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 192. GCC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 193. GCC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. BRICS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. BRICS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. BRICS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 207. BRICS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 208. BRICS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 209. BRICS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 210. BRICS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. BRICS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 212. BRICS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 213. BRICS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. G7 SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 215. G7 SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 216. G7 SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 217. G7 SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 218. G7 SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 219. G7 SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 220. G7 SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 221. G7 SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 222. G7 SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 223. G7 SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. NATO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. NATO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 226. NATO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 227. NATO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 228. NATO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 229. NATO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 230. NATO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. NATO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 232. NATO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 233. NATO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. CHINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 246. CHINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 247. CHINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
TABLE 248. CHINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 249. CHINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2032 (USD MILLION)
TABLE 250. CHINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 251. CHINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. CHINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 253. CHINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2032 (USD MILLION)
TABLE 254. CHINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Sustained Release Injectables market report include:
  • Alkermes plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • DSM-Firmenich Group
  • DURECT Corporation
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Halozyme Therapeutics, Inc.
  • Hoffmann-La Roche Ltd
  • Indivior PLC
  • Johnson & Johnson
  • MedinCell SA
  • Novartis AG
  • Oakwood Laboratories, LLC
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Pharmathen S.A.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • ViiV Healthcare Limited

Table Information

Report AttributeDetails
No. of Pages183
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.6 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.01 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Injectable HIV Treatment Market - Global Forecast 2026-2032 - Product Image

Injectable HIV Treatment Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Sterile Injectable Drugs Market - Global Forecast 2026-2032 - Product Image

Sterile Injectable Drugs Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Injectable Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Injectable Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Generic Injectables: Market Share, and Growth Analysis by Product Type (Powder Injectables, Liquid Injectables, Pre-filled Syringes), Application, End User, Technology - Product Image

Generic Injectables: Market Share, and Growth Analysis by Product Type (Powder Injectables, Liquid Injectables, Pre-filled Syringes), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Injectable Cytotoxic Drugs - Global Strategic Business Report - Product Image

Injectable Cytotoxic Drugs - Global Strategic Business Report

  • Report
  • 380 Pages
  • Global
From

About the Sustained Release Injectable Market

The Sustained Release Injectable market is a subset of the Infusions and Injectables market. It is composed of drugs that are administered via injection and are designed to provide a slow and steady release of the active ingredient over a period of time. This type of drug delivery system is beneficial for patients who require a consistent level of medication over a long period of time. It also reduces the number of injections needed, which can be beneficial for patients who have difficulty with frequent injections. The Sustained Release Injectable market is composed of a variety of drugs, including hormones, antibiotics, and analgesics. These drugs are typically administered via intramuscular or subcutaneous injection, and the active ingredient is slowly released over a period of time. Some companies in the Sustained Release Injectable market include Pfizer, Merck, Novartis, and Sanofi. These companies produce a variety of drugs that are designed to provide a slow and steady release of the active ingredient over a period of time. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.